Straight answers when the meds aren't working

Treatment-resistant depression is a clinical term for major depression that has not responded well to at least two different antidepressants, each taken at an adequate dose for an adequate length of time. It describes how the illness has behaved so far, not a verdict that the person is untreatable. Many people who meet this description respond to other approaches, such as TMS, esketamine, or structured therapy. More in the basics.

Depression has many different underlying causes, and a medication that targets one part of brain chemistry may not match a given person's version of the illness. Sometimes a past medication was never given a full trial because it was stopped early or never reached a full dose. Other times an untreated issue such as a thyroid problem or sleep apnea is holding symptoms in place. This is worth discussing with your doctor rather than assuming nothing can help.

Feeling flat, muted, or emotionally numb rather than sad is a recognized side effect of some antidepressants called emotional blunting. The same chemistry that eases despair can also dampen positive feeling for some people. It is different from depression itself and is a valid reason to revisit your treatment plan. Do not stop medication on your own, because some antidepressants are dangerous to stop abruptly. Instead, describe the numbness to your prescriber, who may adjust the dose, switch medications, or consider a different type of treatment. More in feeling numb on antidepressants.

Established next steps include revisiting the medication strategy in a more deliberate way, structured skills-based therapy such as cognitive behavioral therapy, transcranial magnetic stimulation (TMS), and esketamine (Spravato). Addressing foundations such as sleep, movement, and untreated medical conditions also improves how well other treatments work. These are often layered into one plan rather than tried one at a time. See your options.

Transcranial magnetic stimulation, or TMS, uses focused magnetic pulses to stimulate areas of the brain involved in mood. It is FDA-cleared for depression that has not responded to medication. It is done in a clinic while you are awake, without anesthesia, over a series of short sessions across several weeks. Most people describe it as a tapping sensation on the scalp rather than pain, and they drive themselves home afterward. More in what TMS is like.

Esketamine, sold as Spravato, is an FDA-approved nasal spray treatment for treatment-resistant depression. It is given in a certified medical setting where you are monitored for about two hours afterward, because it works differently from a daily pill and can briefly affect blood pressure and perception. It is usually used alongside an oral antidepressant, and for some people it can ease symptoms faster than traditional medications. It is not a take-home prescription, and you arrange a ride home. More in what Spravato is like.

Esketamine (Spravato) is a specific FDA-approved nasal spray product with a defined in-clinic protocol for treatment-resistant depression. Ketamine therapy is a broader family of ketamine-based treatment that can be given in other supervised formats and is dosed, used, and covered by insurance differently. They are related but not interchangeable, and both should be doctor-supervised.

Both TMS and esketamine are covered by many insurance plans when medical criteria are met, and coverage has broadened in recent years. In Missouri this includes many people on MO HealthNet, the state Medicaid program. Coverage depends on your specific plan and situation, so it is best to confirm details directly with the clinic and your insurer rather than assuming these treatments are out of financial reach. More in depression help in St. Louis.

No. The label describes how your depression has responded to first-line medications so far, not the limit of what is possible. In practice it is often the point at which good care stops repeating the same approach and starts widening the map to treatments designed specifically for people whom standard antidepressants have not reached. Running out of results from one kind of treatment is not the same as running out of options.

Describe the pattern, not just the feeling. Say how many medications you have tried, for how long, and what has and has not changed. Then ask one open question, such as: if the medications we have tried are not working, what else is out there for me? Bringing a written timeline of past medications and side effects helps your doctor see the full picture and makes it easier to ask for a referral to TMS or esketamine. We wrote a full script for that conversation.